article thumbnail

From ECHELON-3 to Clinical Practice: Newly Approved Brentuximab Vedotin With Lenalidomide and Rituximab for R/R DLBCL

Pharmacy Times

These assessments can then be properly communicated to oncologists and patients. Therapeutic and safety monitoring : Pharmacists can assess treatment response, adjust dosing schedules, and monitor for disease progression.

article thumbnail

Compounded semaglutide side effects

The Checkup by Singlecare

Compounded semaglutide is a custom-made version made by licensed compounding pharmacies. Therefore, compounded semaglutide is meant to work the same way and to be almost identical to the brand name semaglutide. Doing so can make it easy to track symptoms and communicate them to your healthcare provider promptly.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Pharmalittle: We’re reading about Novo and GLP-1 compounding, Paxlovid and long Covid, and more

STAT

Food and Drug Administration seeking to block compounding pharmacies in the U.S. The report, published Monday in the journal Communications Medicine, describes the cases of 13 long Covid patients who took extended courses of the antiviral drug. We hope you have a meaningful and manageable day. Best of luck, and do keep in touch.

article thumbnail

OTC Case Studies: Oral Care

Pharmacy Times

Sneha Baxi Srivastava, PharmD, BCACP, CDE, is associate director of skills education at Rosalind Franklin University of Medicine and Science’s College of Pharmacy in North Chicago, Illinois. CASE 2 Infant Teething A father comes to the pharmacy with his 8-month-old baby, JM, who is experiencing noticeable discomfort due to teething.

article thumbnail

Pharmacists Bridge the Gaps in Care Transitions

Pharmacy Times

Effective communication between pharmacists and other health care providers can prevent medication errors and ensure patients receive the best care. This coordination is essential for ensuring that all members of a patient’s health care team are aware of the patient’s medication regimen and any changes made.

article thumbnail

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

Pharmacy Times

The FDA has announced changes to the labeling of all opioid pain medications, including immediate-release and extended-release, to better communicate long-term risks like abuse, addiction, overdose, and drug interactions, according to a news release from the agency. REFERENCES 1.

article thumbnail

STAT+: Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

STAT

We can tell by the speed at which the notes are arriving through the various communications channels on our laptop and phone, and by the number of motor vehicles passing by our window. regulations allow compounding pharmacies to manufacture and sell large quantities of brand-name medicines only if they are in short supply.